The first four draws are not good, but it feels okay, these things may have felt a bit wasteful in the past, but given to the current Bai Ye, it is equivalent to giving Bai Ye a new development field.

In the field of food research and development, Bai Ye is now considering whether he needs to open up a research institute specializing in food research, and then set up a food group, which is done well, and he will have the opportunity to become the richest man in the world?

After thinking about it clearly, Bai Ye felt that it was still a very interesting matter, so he immediately made a decision, picked up a pen and paper, and decided to put this matter in the memo and include it in one of the next key studies.

Although food and drugs are two kinds of things, people who have been used to making drugs for a long time can easily make people feel at ease when they make food, after all, the approval of drugs is strict, and food is much more relaxed.

There is still one last lottery, a six-star lottery, and Bai Ye doesn't know what will be given to him, but he is still looking forward to it.

It's better not to just have a wagon of drinks.

Otherwise, at the end of the year, the unit welfare will not be paid, but drinks should be distributed......

Thinking of this, Bai Ye rubbed his hands and directly started the lottery.

【Ding!Congratulations on obtaining NGS technology!】

After Bai Ye heard this voice, his heart was crisp.

NGS Technology!

This is the NGS technology that Considin mentions every day!

Bai Ye felt very excited and excited when he thought about it.

Suddenly, after Bai Ye saw these three letters, he lost his instinctive reason.

What is NGS?

Maybe most people don't understand it very well, but after the last research on bowel cancer, Bai Ye's genetic engineering technology was completed in an instant, and he has also made great progress and understanding of many professional terms and terms.

The system gives an accurate answer:

[The full name of NGS technology: high-throughput sequencing technology, also known as "next-generation" sequencing technology, is marked by the ability to sequence hundreds of thousands to millions of DNA molecules in parallel at one time and the general short read length. 】

High-throughput sequencing technology is a revolutionary change to traditional sequencing, sequencing hundreds of thousands to millions of DNA molecules at a time, so it is called next-generation sequencing technology in some literature, which shows its epoch-making changes, and high-throughput sequencing makes it possible to analyze the transcriptome and genome of a species in detail, so it is also called deep sequencing.

Suffice it to say, the birth of high-throughput sequencing technology is a milestone event in the field of genomics research.

Taking human genome sequencing as an example, the human genome project at the end of the last century spent $30-10 billion to decode the code of human life, and the second generation sequencing has made human genome sequencing have entered the era of 10,000 (US) metagenomes.

Such a low cost of single-base sequencing allows us to implement genome projects for more species, thereby deciphering the genomic genetic code of more biological species. At the same time, large-scale whole-genome resequencing of other species of the species has also become possible in the species that have been sequenced.

The most important thing is not his sequencing, but what?

NGS technology is a particularly difficult hurdle in the development of SCS (single-cell sequencing) technology.

This difficulty directly limits the development of single-cell sequencing technology.

Single-cell sequencing technology is the bottom-of-the-box technology of the Considin laboratory, which can observe the gene sequence information of a single cell through next-generation sequencing and NGS technology, so as to obtain the differences in genetic material and protein information between cells, so as to better understand the function of a single minority of cells in their microenvironment.

By sequencing the whole genome, transcriptome, and genetics of cell expression of individual tumor cells, it is possible to unfold complex mechanisms within tumor cells.

At present, single-cell sequencing technology, also known as SCS technology, is currently the world's leading tumor research and development technology, and it is also the treasure technology at the bottom of the box of the old man Conxitin, and he can be said to be very good at this industry.

Last time, it was precisely because of the help of Considin and Morstein that Bai Ye's research progress continued to accelerate.

At the beginning, Bai Ye clearly remembered that Kang Xiding said that if high-throughput sequencing technology-NGS technology can develop rapidly, his single-cell sequencing technology will definitely shine.

He even has an eye for high-throughput sequencing technology and even a key technology for future development!

This involves a function of genetic engineering and tumor prevention.

After all, the combination of high-throughput measurement technology and single-cell sequencing technology can predict the development direction and trend of the next generation of cells, which is of great help to cells.

Bai Ye took a deep breath and calmed down the excitement in his heart.

What a baby!

With such a technology in hand, what are you worried about?

Although NGS single-cell sequencing technology is difficult, Bai Ye has also learned a lot, especially relying on those expensive instruments, Bai Ye can also try.

Besides, John is also a big name in the field of genes, in case people also have some good technology to press the bottom of the box, isn't this Yang a perfect thing?

Bai Ye got up excitedly and walked back and forth, feeling happy in his heart.

Roche Group, let's compare this time to see who can win.

Originally, Bai Ye was worthy of the Roche Group, but now with NGS high-throughput sequencing technology, he is even more intimidated.

No matter how strong Bona and them are, Bai Ye will not be intimidated at all anyway.

At this time, a meeting was being held within the implementation group, which brought together all the top management of the entire Roche.

But only seven people sat at the front.

Among these seven people, there are former members of the R&D team of the proxican drug: Bona, Consitin, and Mostin.

The other four did not feel at all embarrassed or unnatural to sit with the three of them, because their status was not inferior to that of Bona and the others.

The Roche Group can have today, naturally relying on not vain things, but relying on strength.

This time, Roche Group invited the Nobel Prize winners from the last two or three sessions, and several of them are currently attracting more attention in the field of cytology.

With the addition of these seven great members at the same time, coupled with the lineup of academicians, it can be said that this time Roche Group has made a big price for this tumor research.

In fact, after the Luo Group was rejected by Bai Ye, he made up his mind to do it himself.

For this reason, he spared no expense to invite Bona and others, as for the means, it is not important.

Even they are ready for a showdown.

Roche Group can get to this day, naturally it will not be frightened by a newcomer, and it can still support it in a battle with Pfizer until now, he relies not on luck, but on strength!